Slocum, Gordon & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.93M | Sell |
21,146
-254
| -1% | -$47.1K | 3.16% | 11 |
|
|
2025
Q1 | $4.48M | Sell |
21,400
-16,917
| -44% | -$3.54M | 3.34% | 11 |
|
|
2024
Q4 | $6.81M | Sell |
38,317
-1,857
| -5% | -$330K | 5.6% | 5 |
|
|
2024
Q3 | $7.93M | Sell |
40,174
-2,282
| -5% | -$451K | 3.19% | 9 |
|
|
2024
Q2 | $7.28M | Sell |
42,456
-58
| -0.1% | -$9.95K | 5.42% | 6 |
|
|
2024
Q1 | $7.74M | Sell |
42,514
-30
| -0.1% | -$5.46K | 5.75% | 5 |
|
|
2023
Q4 | $6.59M | Buy |
42,544
+250
| +0.6% | +$38.7K | 5.79% | 5 |
|
|
2023
Q3 | $6.3M | Sell |
42,294
-850
| -2% | -$127K | 5.49% | 5 |
|
|
2023
Q2 | $5.81M | Sell |
43,144
-260
| -0.6% | -$35K | 4.22% | 10 |
|
|
2023
Q1 | $6.92M | Sell |
43,404
-12,850
| -23% | -$2.05M | 5.74% | 6 |
|
|
2022
Q4 | $9.09M | Buy |
+56,254
| New | +$9.09M | 5.86% | 6 |
|